News & Perspective
Drugs & Diseases
CME & Education
Academy
Video
Decision Point
Specialty:
Multispecialty
Allergy & Immunology
Anesthesiology
Cardiology
Critical Care
Dermatology
Diabetes & Endocrinology
Emergency Medicine
Family Medicine
Gastroenterology
General Surgery
Hematology - Oncology
HIV/AIDS
Hospital Medicine
Infectious Diseases
Internal Medicine
Multispecialty
Nephrology
Neurology
Ob/Gyn & Women's Health
Oncology
Ophthalmology
Orthopedics
Pathology & Lab Medicine
Pediatrics
Plastic Surgery
Psychiatry
Public Health
Pulmonary Medicine
Radiology
Rheumatology
Transplantation
Urology
Today on Medscape
Business of Medicine
Medical Lifestyle
Science & Technology
Medical Students
Nurses
Pharmacists
Residents
Edition:
English
Medscape
English
Deutsch
Español
Français
Português
UK
New
Univadis
Log In
Sign Up It's Free!
English Edition
Medscape
English
Deutsch
Español
Français
Português
UK
New
Univadis
X
Univadis
from
Medscape
Register
Log In
No Results
No Results
Thursday, March 23, 2023
News & Perspective
Drugs & Diseases
CME & Education
Academy
Video
Decision Point
close
Please confirm that you would like to log out of Medscape. If you log out, you will be required to enter your username and password the next time you visit.
Log out
Cancel
From
theheart.org on Medscape
News from the:
High Blood Pressure Research (HBPR) 2014 Scientific Sessions
September 09 - 12, 2014; San Francisco, California
Conference News
HBPR
New-Onset Diabetes in Hypertension Patients: No Added Risks
Heartwire from Medscape
, September 16, 2014
HBPR
New Hyperkalemia Drug Safe, Effective in Phase 3 Trial
Heartwire from Medscape
, September 13, 2014
HBPR
Hypertension ER Visits Surge 25% in Five Years
Heartwire from Medscape
, September 11, 2014
Previous Coverage
HBPR 2012
Related Resources
Hypertension News & Perspectives